Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Theodoros A Zografos , Demosthenes G Katritsis Added: 3 years ago
Atrial Fibrillation(AF) affects 1-2 % of the population, and its prevalence is expected to increase in the next 50 years.1,2 The treatment of these patients includes either restoration and maintenance of sinus rhythm (SR) or control of the ventricular rate.3 Electrical cardioversion (ECV) can be effective in restoring SR in the majority of patients; however, it is associated with several risks… View more
Author(s): Jakob Luker Added: 5 years ago
Dr Jakob Lüker (University Hospital Cologne, DE) discusses internal vs. external electrical cardioversion of atrail arrhythmias in patients with an implantable cardioverter-defibrillator (ICD). Filmed on site by Radcliffe Cardiology. Questions: 1. What is the concern with atrial conversions in patients with AICDs (automated implantable cardioverter defibrillator)? (00:10) 2. How does… View more
Dr Duncan Hogg, gained his medical qualification at the University of Aberdeen in 1994. In 1997 he became a Member of the Royal College of Physicians. Dr Hogg received his general cardiology training at Aberdeen Royal Infirmary and completed specialist training in Cardiology & General Internal Medicine (GIM) in 2007. Dr Hogg has Specialist Registration with the General Medical Council for… View more
Author(s): Angela Hall , Andrew RJ Mitchell Added: 3 years ago
AF is the most common clinical arrhythmia, affecting at least 1–2% of the population.1,2 Its prevalence increases with age, with 5% of people aged over 65 years developing AF, climbing to 8% in those aged over 75 years.3 AF is associated with increased morbidity and mortality and has significant public health implications.4 Patients presenting with new onset AF to emergency departments can be… View more
Author(s): Philipp Bushoven , Sven Linzbach , Mate Vamos , et al Added: 3 years ago
Atrial Fibrillation, Cardioversion and Stroke Risk Atrial fibrillation (AF) is the most common serious chronic heart rhythm disorder with an estimated prevalence in the general population of around 1%.1 The arrhythmia affects about 2.2 million persons in the US and 4.5 million individuals in the EU. Due to the advancing age of the population, the prevalence of AF is likely to increase even… View more
Author(s): Andreas Goette , Hein Heidbuchel Added: 3 years ago
AF is the most common sustained cardiac arrhythmia and poses a significant public health challenge.1 In cases of AF, if sinus rhythm does not spontaneously return, cardioversion may be needed to alleviate symptoms and to improve cardiac performance.2 This may be performed by pharmacological methods, i.e. the administration of antiarrhythmic drugs, which is the preferred strategy in recent-onset… View more
Author(s): Demosthenes G Katritsis , Giuseppe Boriani , Francisco G Cosio , et al Added: 3 years ago
Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE) This is an executive summary of the full consensus document on the management of supraventricular tachycardia (SVT) patients published in Europace. The consensus document was prepared by a Task Force from the European Heart Rhythm… View more
Author(s): Jonathan S Steinberg , David Slotwiner Added: 3 years ago
Electrical Remodelling Evidence Supporting Atrial Remodelling The concept of electrical remodelling was first introduced in 1995 simultaneously by Wijffels et al.1 and Morillo et al.2 who demonstrated that once sustained atrial fibrillation (AF) was induced in goats, or rapid atrial pacing was performed in dogs, physiological changes occurred that favoured the maintenance of AF.3 This led to the… View more
Author(s): Francesco Orso , Gianna Fabbri , Aldo Pietro Maggioni Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and confers increased risk of death,1 thromboembolism and impaired quality of life.2 Current pharmacological antiarrhythmic drugs provide limited protection against AF recurrence and have poor safety profiles, while invasive ablation treatments are associated with significant risks and limited long-term success rates… View more